IBDEI2G3 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41469,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,41469,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,41470,0)
 ;;=Z82.71^^159^2005^47
 ;;^UTILITY(U,$J,358.3,41470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41470,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,41470,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,41470,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,41471,0)
 ;;=Z82.1^^159^2005^23
 ;;^UTILITY(U,$J,358.3,41471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41471,1,3,0)
 ;;=3^Family Hx of Blindness/Visual Loss
 ;;^UTILITY(U,$J,358.3,41471,1,4,0)
 ;;=4^Z82.1
 ;;^UTILITY(U,$J,358.3,41471,2)
 ;;=^5063365
 ;;^UTILITY(U,$J,358.3,41472,0)
 ;;=Z82.2^^159^2005^27
 ;;^UTILITY(U,$J,358.3,41472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41472,1,3,0)
 ;;=3^Family Hx of Deafness/Hearing Loss
 ;;^UTILITY(U,$J,358.3,41472,1,4,0)
 ;;=4^Z82.2
 ;;^UTILITY(U,$J,358.3,41472,2)
 ;;=^5063366
 ;;^UTILITY(U,$J,358.3,41473,0)
 ;;=Z84.0^^159^2005^48
 ;;^UTILITY(U,$J,358.3,41473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41473,1,3,0)
 ;;=3^Family Hx of Skin Diseases
 ;;^UTILITY(U,$J,358.3,41473,1,4,0)
 ;;=4^Z84.0
 ;;^UTILITY(U,$J,358.3,41473,2)
 ;;=^5063388
 ;;^UTILITY(U,$J,358.3,41474,0)
 ;;=Z82.79^^159^2005^26
 ;;^UTILITY(U,$J,358.3,41474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41474,1,3,0)
 ;;=3^Family Hx of Congen Malform,Deformations & Chromsoml Abnlt
 ;;^UTILITY(U,$J,358.3,41474,1,4,0)
 ;;=4^Z82.79
 ;;^UTILITY(U,$J,358.3,41474,2)
 ;;=^5063374
 ;;^UTILITY(U,$J,358.3,41475,0)
 ;;=Z84.89^^159^2005^46
 ;;^UTILITY(U,$J,358.3,41475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41475,1,3,0)
 ;;=3^Family Hx of Other Spec Conditions
 ;;^UTILITY(U,$J,358.3,41475,1,4,0)
 ;;=4^Z84.89
 ;;^UTILITY(U,$J,358.3,41475,2)
 ;;=^5063393
 ;;^UTILITY(U,$J,358.3,41476,0)
 ;;=Z81.1^^159^2005^20
 ;;^UTILITY(U,$J,358.3,41476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41476,1,3,0)
 ;;=3^Family Hx of Alcohol Abuse/Dependence
 ;;^UTILITY(U,$J,358.3,41476,1,4,0)
 ;;=4^Z81.1
 ;;^UTILITY(U,$J,358.3,41476,2)
 ;;=^5063359
 ;;^UTILITY(U,$J,358.3,41477,0)
 ;;=Z82.62^^159^2005^45
 ;;^UTILITY(U,$J,358.3,41477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41477,1,3,0)
 ;;=3^Family Hx of Osteoporosis
 ;;^UTILITY(U,$J,358.3,41477,1,4,0)
 ;;=4^Z82.62
 ;;^UTILITY(U,$J,358.3,41477,2)
 ;;=^5063372
 ;;^UTILITY(U,$J,358.3,41478,0)
 ;;=Z83.71^^159^2005^25
 ;;^UTILITY(U,$J,358.3,41478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41478,1,3,0)
 ;;=3^Family Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,41478,1,4,0)
 ;;=4^Z83.71
 ;;^UTILITY(U,$J,358.3,41478,2)
 ;;=^5063386
 ;;^UTILITY(U,$J,358.3,41479,0)
 ;;=Z84.81^^159^2005^29
 ;;^UTILITY(U,$J,358.3,41479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41479,1,3,0)
 ;;=3^Family Hx of Genetic Disease
 ;;^UTILITY(U,$J,358.3,41479,1,4,0)
 ;;=4^Z84.81
 ;;^UTILITY(U,$J,358.3,41479,2)
 ;;=^5063392
 ;;^UTILITY(U,$J,358.3,41480,0)
 ;;=Z86.010^^159^2005^76
 ;;^UTILITY(U,$J,358.3,41480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41480,1,3,0)
 ;;=3^Personal Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,41480,1,4,0)
 ;;=4^Z86.010
 ;;^UTILITY(U,$J,358.3,41480,2)
 ;;=^5063456
 ;;^UTILITY(U,$J,358.3,41481,0)
 ;;=Z86.14^^159^2005^81
 ;;^UTILITY(U,$J,358.3,41481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41481,1,3,0)
 ;;=3^Personal Hx of MRSA Infection
 ;;^UTILITY(U,$J,358.3,41481,1,4,0)
 ;;=4^Z86.14
 ;;^UTILITY(U,$J,358.3,41481,2)
 ;;=^5063464
 ;;^UTILITY(U,$J,358.3,41482,0)
 ;;=Z86.31^^159^2005^77
 ;;^UTILITY(U,$J,358.3,41482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41482,1,3,0)
 ;;=3^Personal Hx of Diabetic Foot Ulcer
